These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 10980447)
21. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2. García-Martínez LF; Mavankal G; Peters P; Wu-Baer F; Gaynor RB J Mol Biol; 1995 Dec; 254(3):350-63. PubMed ID: 7490754 [TBL] [Abstract][Full Text] [Related]
22. Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpression. Missé D; Gajardo J; Oblet C; Religa A; Riquet N; Mathieu D; Yssel H; Veas F AIDS; 2005 Jun; 19(9):897-905. PubMed ID: 15905670 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37. Okamoto H; Cujec TP; Okamoto M; Peterlin BM; Baba M; Okamoto T Virology; 2000 Jul; 272(2):402-8. PubMed ID: 10873784 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists. Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455 [TBL] [Abstract][Full Text] [Related]
26. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots". Davis B; Afshar M; Varani G; Murchie AI; Karn J; Lentzen G; Drysdale M; Bower J; Potter AJ; Starkey ID; Swarbrick T; Aboul-ela F J Mol Biol; 2004 Feb; 336(2):343-56. PubMed ID: 14757049 [TBL] [Abstract][Full Text] [Related]
27. Anti-human immunodeficiency virus type 1 activity of an oligocationic compound mediated via gp120 V3 interactions. O'Brien WA; Sumner-Smith M; Mao SH; Sadeghi S; Zhao JQ; Chen IS J Virol; 1996 May; 70(5):2825-31. PubMed ID: 8627756 [TBL] [Abstract][Full Text] [Related]
28. Discovery of selective, small-molecule inhibitors of RNA complexes--I. The Tat protein/TAR RNA complexes required for HIV-1 transcription. Mei HY; Mack DP; Galan AA; Halim NS; Heldsinger A; Loo JA; Moreland DW; Sannes-Lowery KA; Sharmeen L; Truong HN; Czarnik AW Bioorg Med Chem; 1997 Jun; 5(6):1173-84. PubMed ID: 9222511 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element. Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220 [TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and biological activity of a cyclic peptide: an inhibitor of HIV-1 tat-TAR interactions in human cells. Tamilarasu N; Huq I; Rana TM Bioorg Med Chem Lett; 2000 May; 10(9):971-4. PubMed ID: 10853671 [TBL] [Abstract][Full Text] [Related]
32. Inhibitors of HIV-1 Tat-mediated transactivation. Richter SN; Palù G Curr Med Chem; 2006; 13(11):1305-15. PubMed ID: 16712471 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of human immunodeficiency virus type 1 Tat-dependent activation of translation in Xenopus oocytes by the benzodiazepine Ro24-7429 requires trans-activation response element loop sequences. Braddock M; Cannon P; Muckenthaler M; Kingsman AJ; Kingsman SM J Virol; 1994 Jan; 68(1):25-33. PubMed ID: 8254735 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of human immunodeficiency virus type 1 tat-trans-activation-responsive region interaction by an antiviral quinolone derivative. Richter S; Parolin C; Gatto B; Del Vecchio C; Brocca-Cofano E; Fravolini A; Palù G; Palumbo M Antimicrob Agents Chemother; 2004 May; 48(5):1895-9. PubMed ID: 15105155 [TBL] [Abstract][Full Text] [Related]
35. Translational effects of peptide antagonists of Tat protein of human immunodeficiency virus type 1. Choudhury I; Wang J; Stein S; Rabson A; Leibowitz MJ J Gen Virol; 1999 Mar; 80 ( Pt 3)():777-782. PubMed ID: 10092019 [TBL] [Abstract][Full Text] [Related]
36. Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system. Xie B; Calabro V; Wainberg MA; Frankel AD J Virol; 2004 Feb; 78(3):1456-63. PubMed ID: 14722301 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of HIV tat-TAR interactions by an antisense oligo-2'-O-methylribonucleoside methylphosphonate. Hamma T; Saleh A; Huq I; Rana TM; Miller PS Bioorg Med Chem Lett; 2003 Jun; 13(11):1845-8. PubMed ID: 12749881 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of HIV-1 TAR RNA-Tat peptide complexation using poly(acrylic acid). Zhao H; Li J; Jiang L Biochem Biophys Res Commun; 2004 Jul; 320(1):95-9. PubMed ID: 15207707 [TBL] [Abstract][Full Text] [Related]